BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8847905)

  • 1. International conference on chronic myelocytic leukemia: biology and treatment organised by the Scientific Committee of The Israel Society of Hematology, Jerusalem, Israël, 28-31 January 1996.
    Janković GM; Colović MD
    Leukemia; 1996 Oct; 10(10):1667-70. PubMed ID: 8847905
    [No Abstract]   [Full Text] [Related]  

  • 2. The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.
    Fernandes RS; Gorman AM; McGahon A; Lawlor M; McCann S; Cotter TG
    Leukemia; 1996 Jun; 10 Suppl 2():s17-21. PubMed ID: 8649049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Co-expression of major and minor bcr/abl in chronic myelogenous leukemia].
    Sugimoto T; Murayama T; Mizuno I; Hato A; Imoto S; Saigo K; Kumagai S; Nishimura R; Koizumi T
    Rinsho Ketsueki; 2003 Mar; 44(3):139-43. PubMed ID: 12722339
    [No Abstract]   [Full Text] [Related]  

  • 4. Ribozyme mediated therapy for chronic myelogenous leukemia.
    Leopold LH; Shore SK; Newkirk T; Mangan K; Reddy EP
    Prog Clin Biol Res; 1994; 389():175-82. PubMed ID: 7700900
    [No Abstract]   [Full Text] [Related]  

  • 5. A t(20;21)(q12;q22.3) in a patient with chronic myelocytic leukemia in blastic phase.
    Gozzetti A; Tozzuoli D; Crupi R; Gentili S; Raspadori D; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2004 Apr; 150(1):90-1. PubMed ID: 15041233
    [No Abstract]   [Full Text] [Related]  

  • 6. Guest editorial: chronic myeloid leukemia.
    Minami Y
    Int J Hematol; 2018 Oct; 108(4):353-354. PubMed ID: 30155590
    [No Abstract]   [Full Text] [Related]  

  • 7. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelogenous leukemia: biology and therapy.
    Gale RP; Grosveld G; Canaani E; Goldman JM
    Leukemia; 1993 Apr; 7(4):653-8. PubMed ID: 8464245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the treatment of chronic myelocytic leukemia].
    Pawelski S
    Pol Tyg Lek; 1990 Dec 17-31; 45(51-52):1027-31. PubMed ID: 2098740
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring M-BCR-ABL expression level in CML patients by RQ-PCR: experience of a single Center.
    Szántó A; Pap Z; Benedek I; Benedek-Lázár E; Köpeczi JB; Tunyogi AB; Vasile K; Horváth E; Pávai Z
    Rom J Morphol Embryol; 2013; 54(1):37-42. PubMed ID: 23529307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chronic myelocytic cell line K 562 contains minor (m) as well as major (M) ber/abl fusion mRNAs.
    Seelig R; Schranz P; Bottner C; Neubauer A; Seelig HP; Renz M
    Leukemia; 1993 Nov; 7(11):1886-7. PubMed ID: 8231257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic myelocytic leukemia].
    Asano S
    Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):357-62. PubMed ID: 7525806
    [No Abstract]   [Full Text] [Related]  

  • 14. The biology of chronic myelogenous leukemia progression: who, what, where, and why?
    Radich JP
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):967-80, v. PubMed ID: 22054729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
    Beel KA; Lemmens J; Vranckx H; Maertens J; Vandenberghe P
    Ann Hematol; 2011 Oct; 90(10):1241-3. PubMed ID: 21302112
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukemia--advances in biology and new approaches to treatment.
    Goldman JM; Melo JV
    N Engl J Med; 2003 Oct; 349(15):1451-64. PubMed ID: 14534339
    [No Abstract]   [Full Text] [Related]  

  • 17. Autografting for chronic myelocytic leukemia.
    McGlave P
    Bone Marrow Transplant; 1994; 14 Suppl 3():S49-50. PubMed ID: 7697008
    [No Abstract]   [Full Text] [Related]  

  • 18. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
    Chai SK; Nichols GL; Rothman P
    J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematology clinic: chronic myelogenous leukemia.
    Weber AA; Talpaz M
    Hematology; 2013 Nov; 18(6):372-3. PubMed ID: 24129094
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic myelocytic leukemia].
    Shibata A
    Rinsho Ketsueki; 1989 Aug; 30(8):1190-2. PubMed ID: 2481049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.